Biopharma manufacturing poised to expand

Certain segments of the biopharmaceutical manufacturing industry are set to make big leaps in capacity over the next five years. Where will that expansion take place? Nope, not in Asia. Europe's the big beneficiary here. Report

Suggested Articles

Pfizer's diagnosis-focused launch strategy for Vyndaqel and Vyndamax is paying off with the meds reaching thousands of patients already.

Pfizer terminated a slew of trial cohorts testing Bavencio in combination with its own experimental drugs, as well as one monotherapy trial.

With its Eli Lilly-partnered Olumiant nearing filing in atopic dermatitis, Incyte's other JAK med Jakafi is also looking for a win in that indication.